News

Eli Lilly reported impressive data at the recent American Diabetes Association ('ADA') conference. Its robust pipeline will ...
Some weight loss drugs may cause hair loss. While it’s typically a temporary side effect, it can affect your confidence.
Deep-pocketed investors have adopted a bullish approach towards Eli Lilly LLY, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this ...
Eli Lilly’s Zepbound transformed weight loss drug market since debut 18 months ago 4.5 million people reportedly taking Lilly ...
LLY has slid 15.7% over the past year, but surging demand for Mounjaro and Zepbound could revive the stock's momentum.
Obesity medications, once facing shortages, are now widely available. So how do consumers not get scammed into purchasing ...
In today's dynamic and volatile market terrain, investors are increasingly drawn to opportunities that promise robust growth ...
Recently, the United States has witnessed an intense legal and commercial confrontation between major pharmaceutical ...
Novo Nordisk's beaten-down valuation became too attractive to pass up, so I bought the stock earlier this year. Eli Lilly's ...